Advertisement
Home »

LuPSMA & Enzalutamide: A Promising Combination

Oct 26, 2023

REFERENCES & ADDITIONAL READING

Beer TM, Armstrong AJ, Rathkopf DE, et al. N Engl J Med. 2014;371:424-433. DOI: 10.1056/NEJMoa1405095

 

Sartor O, de Bono J, Chi KN, et al. N Engl J Med. 2021;385:1091-1103. DOI: 10.1056/NEJMoa2107322

 

Emmett L, Subramaniam S, Crumbaker M, et al. Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomized, phase II trial: ENZA-p (ANZUP 1901). Abstract LBA84, ESMO 2023, 20-24 October, Madrid, Spain.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement